A Chinese Covid-19 Vaccine Has Proved Effective, Its Maker Says
Published
Sinopharm, a state-controlled company, said its candidate had a 79 percent efficacy rate in interim late-stage trials, bringing a...
Full ArticlePublished
Sinopharm, a state-controlled company, said its candidate had a 79 percent efficacy rate in interim late-stage trials, bringing a...
Full ArticleBut state-run Butantan research institute is withholding results of trials at request of Chinese drug maker Sinovac
The U.A.E. said it reviewed an analysis by Sinopharm, a Chinese state-owned vaccine maker, of data from late-stage clinical trials...